Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$13.02
At close: Apr 7 EDT
$13.02
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Medifast Analyst Ratings and Price Targets | NYSE:MED | Benzinga
Medifast Inc has a consensus price target of $82.83 based on the ratings of 3 analysts. The high is $150 issued by Jefferies on August 4, 2022. The low is $16.5 issued by DA Davidson on February 19, 2025. The 3 most-recent analyst ratings were released by DA Davidson on February 19, 2025, November 5, 2024, and July 22, 2024, respectively. With an average price target of $17 between DA Davidson, there's an implied 30.57% upside for Medifast Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
DA Davidson
Stephens & Co.
Jefferies
1calculated from analyst ratings
Analyst Ratings for Medifast
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/19/2025 | Buy Now | 26.73% | DA Davidson | Linda Bolton Weiser55% | $17 → $16.5 | Maintains | Neutral | Get Alert |
| 11/05/2024 | Buy Now | 30.57% | DA Davidson | Linda Bolton Weiser55% | $16.5 → $17 | Upgrade | Underperform → Neutral | Get Alert |
| 07/22/2024 | Buy Now | 34.41% | DA Davidson | Linda Bolton Weiser55% | $17.5 → $17.5 | Maintains | Underperform | Get Alert |
| 06/05/2024 | Buy Now | 34.41% | DA Davidson | Linda Bolton Weiser55% | $25 → $17.5 | Downgrade | Neutral → Underperform | Get Alert |
| 04/30/2024 | Buy Now | 92.01% | DA Davidson | Linda Bolton Weiser55% | $40 → $25 | Maintains | Neutral | Get Alert |
| 02/21/2024 | Buy Now | 207.22% | DA Davidson | Linda Bolton Weiser55% | $67 → $40 | Maintains | Neutral | Get Alert |
| 10/13/2023 | Buy Now | 529.8% | Stephens & Co. | Jim Salera41% | → $82 | Initiates | → Equal-Weight | Get Alert |
| 08/08/2023 | Buy Now | 514.44% | DA Davidson | Linda Bolton Weiser55% | $93 → $80 | Maintains | Neutral | Get Alert |
| 07/31/2023 | Buy Now | 614.29% | DA Davidson | Linda Bolton Weiser55% | $75 → $93 | Maintains | Neutral | Get Alert |
| 05/02/2023 | Buy Now | 445.31% | DA Davidson | Linda Bolton Weiser55% | $94 → $71 | Maintains | Neutral | Get Alert |
| 02/22/2023 | Buy Now | 621.97% | DA Davidson | Linda Bolton Weiser55% | $106 → $94 | Maintains | Neutral | Get Alert |
| 11/04/2022 | Buy Now | 714.13% | DA Davidson | Linda Bolton Weiser55% | $278 → $106 | Downgrade | Buy → Neutral | Get Alert |
| 08/04/2022 | Buy Now | 2035.18% | DA Davidson | Linda Bolton Weiser55% | $352 → $278 | Maintains | Buy | Get Alert |
| 08/04/2022 | Buy Now | 1052.07% | Jefferies | Stephanie Wissink78% | $345 → $150 | Downgrade | Buy → Hold | Get Alert |
| 06/02/2022 | Buy Now | 2603.53% | DA Davidson | Linda Bolton Weiser55% | $341 → $352 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Medifast (MED) stock?
The latest price target for Medifast (NYSE:MED) was reported by DA Davidson on February 19, 2025. The analyst firm set a price target for $16.50 expecting MED to rise to within 12 months (a possible 26.73% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Medifast (MED)?
The latest analyst rating for Medifast (NYSE:MED) was provided by DA Davidson, and Medifast maintained their neutral rating.
When was the last upgrade for Medifast (MED)?
The last upgrade for Medifast Inc happened on November 5, 2024 when DA Davidson raised their price target to $17. DA Davidson previously had an underperform for Medifast Inc.
When was the last downgrade for Medifast (MED)?
The last downgrade for Medifast Inc happened on June 5, 2024 when DA Davidson changed their price target from $25 to $17.5 for Medifast Inc.
When is the next analyst rating going to be posted or updated for Medifast (MED)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medifast, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medifast was filed on February 19, 2025 so you should expect the next rating to be made available sometime around February 19, 2026.
Is the Analyst Rating Medifast (MED) correct?
While ratings are subjective and will change, the latest Medifast (MED) rating was a maintained with a price target of $17.00 to $16.50. The current price Medifast (MED) is trading at is $13.02, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.